Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin

The devastating pandemic due to SARS‐CoV‐2 and the emergence of antigenic variants that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive understanding of the pathophysiology of COVID‐19, including the contribution of inflammation to disease. It also warrants for...

Descripción completa

Detalles Bibliográficos
Autores principales: de Melo, Guilherme Dias, Lazarini, Françoise, Larrous, Florence, Feige, Lena, Kornobis, Etienne, Levallois, Sylvain, Marchio, Agnès, Kergoat, Lauriane, Hardy, David, Cokelaer, Thomas, Pineau, Pascal, Lecuit, Marc, Lledo, Pierre‐Marie, Changeux, Jean‐Pierre, Bourhy, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350903/
https://www.ncbi.nlm.nih.gov/pubmed/34170074
http://dx.doi.org/10.15252/emmm.202114122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350903/
https://www.ncbi.nlm.nih.gov/pubmed/34170074
http://dx.doi.org/10.15252/emmm.202114122

Ejemplares similares